409 related articles for article (PubMed ID: 15694923)
21. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
Schilström B; Ivanov VB; Wiker C; Svensson TH
Neuropsychopharmacology; 2007 Jan; 32(1):43-53. PubMed ID: 16641937
[TBL] [Abstract][Full Text] [Related]
22. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective and antiamnesic effect of donepezil, a nicotinic acetylcholine-receptor activator, on rats with concussive mild traumatic brain injury.
Fujiki M; Kubo T; Kamida T; Sugita K; Hikawa T; Abe T; Ishii K; Kobayashi H
J Clin Neurosci; 2008 Jul; 15(7):791-6. PubMed ID: 18407501
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.
Kume T; Sugimoto M; Takada Y; Yamaguchi T; Yonezawa A; Katsuki H; Sugimoto H; Akaike A
Eur J Pharmacol; 2005 Dec; 527(1-3):77-85. PubMed ID: 16313899
[TBL] [Abstract][Full Text] [Related]
25. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
[TBL] [Abstract][Full Text] [Related]
26. Switching cholinesterase inhibitors in patients with Alzheimer's disease.
Emre M
Int J Clin Pract Suppl; 2002 Jun; (127):64-72. PubMed ID: 12139369
[TBL] [Abstract][Full Text] [Related]
27. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil.
Sharma B; Singh N; Singh M
J Psychopharmacol; 2008 Mar; 22(2):162-71. PubMed ID: 18208924
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.
Wiker C; Schilström B; Sandbäck C; Wadenberg ML; Svensson TH
Int J Neuropsychopharmacol; 2008 Sep; 11(6):845-50. PubMed ID: 18405415
[TBL] [Abstract][Full Text] [Related]
29. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Wang H; Tang XC
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753
[TBL] [Abstract][Full Text] [Related]
30. Study of neuroprotection of donepezil, a therapy for Alzheimer's disease.
Akasofu S; Kimura M; Kosasa T; Sawada K; Ogura H
Chem Biol Interact; 2008 Sep; 175(1-3):222-6. PubMed ID: 18571635
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacological profiles of galantamine: the involvement of muscarinic receptor].
Matsuda T; Ago Y; Takuma K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Feb; 32(1):1-8. PubMed ID: 22568120
[TBL] [Abstract][Full Text] [Related]
32. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice.
Saxena G; Singh SP; Agrawal R; Nath C
Eur J Pharmacol; 2008 Mar; 581(3):283-9. PubMed ID: 18234183
[TBL] [Abstract][Full Text] [Related]
33. Donepezil, but not galantamine, blocks muscarinic receptor-mediated in vitro and in vivo responses.
Ago Y; Koda K; Ota Y; Kita Y; Fukada A; Takuma K; Matsuda T
Synapse; 2011 Dec; 65(12):1373-7. PubMed ID: 21780184
[TBL] [Abstract][Full Text] [Related]
34. Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.
Nordberg A; Darreh-Shori T; Peskind E; Soininen H; Mousavi M; Eagle G; Lane R
Curr Alzheimer Res; 2009 Feb; 6(1):4-14. PubMed ID: 19199870
[TBL] [Abstract][Full Text] [Related]
35. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
Cerbai F; Giovannini MG; Melani C; Enz A; Pepeu G
Eur J Pharmacol; 2007 Oct; 572(2-3):142-50. PubMed ID: 17643410
[TBL] [Abstract][Full Text] [Related]
36. The combination of donepezil and procyclidine protects against soman-induced seizures in rats.
Haug KH; Myhrer T; Fonnum F
Toxicol Appl Pharmacol; 2007 Apr; 220(2):156-63. PubMed ID: 17289099
[TBL] [Abstract][Full Text] [Related]
37. Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.
Koda K; Ago Y; Kawasaki T; Hashimoto H; Baba A; Matsuda T
Psychopharmacology (Berl); 2008 Feb; 196(2):293-301. PubMed ID: 17912499
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death.
Noh MY; Koh SH; Kim Y; Kim HY; Cho GW; Kim SH
J Neurochem; 2009 Mar; 108(5):1116-25. PubMed ID: 19077054
[TBL] [Abstract][Full Text] [Related]
39. Physiological and neurobehavioral effects of cholinesterase inhibition in healthy adults.
Morasch KC; Aaron CL; Moon JE; Gordon RK
Physiol Behav; 2015 Jan; 138():165-72. PubMed ID: 25455867
[TBL] [Abstract][Full Text] [Related]
40. Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease.
Davidsson P; Blennow K; Andreasen N; Eriksson B; Minthon L; Hesse C
Neurosci Lett; 2001 Mar; 300(3):157-60. PubMed ID: 11226635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
